Scientific Evaluation of One or Two Doses of the Bivalent or Nonavalent Prophylactic HPV Vaccines

Conditions:   Cervical Cancer;   Cervical HPV Infection;   Anti-HPV Antibody Patterns Interventions:   Biological: Cervarix;   Biological: Gardasil 9 Sponsor:   National Cancer Institute (NCI) Not yet recruiting - verified June 1, 2017 (Source: ClinicalTrials.gov)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2s8URw3
via IFTTT